Literature DB >> 15784168

Important roles of reversible acetylation in the function of hematopoietic transcription factors.

Xiaofang Huo1, Junwu Zhang.   

Abstract

Hematopoiesis is a very complex process whose proper functioning requires the regulated action of a number of transcription factors. Histone acetyltransferases (HATs) and histone deacetylases (HDACs) play significant roles in the regulation of hematopoietic transcription factors activity. Transcription factors such as GATA-1, EKLF, NF-E2, GATA-1, PU.1 recruit HATs and HDACs to chromatin, leading to histone acetylation and deacetylation, that affect chromatin structure and result in gene expression changes. On the other hand, transcription factors themselves can be acetylated and deacetylated by HATs and HDACs, respectively. Consequently, some important functions of these transcription factors are influenced, including DNA binding, transcription activation, repressor activity and proteinprotein interactions. The regulation of hematopoietic transcription factors activity by HATs and HDACs may serve as a good model for studying how tissue-specific and lineage-specific gene expression is controlled through acetylation/ deacetylation of histone/nonhistone proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15784168      PMCID: PMC6741356          DOI: 10.1111/j.1582-4934.2005.tb00340.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  54 in total

1.  ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation.

Authors:  H Kawasaki; L Schiltz; R Chiu; K Itakura; K Taira; Y Nakatani; K K Yokoyama
Journal:  Nature       Date:  2000-05-11       Impact factor: 49.962

Review 2.  CREB-binding protein and p300: molecular integrators of hematopoietic transcription.

Authors:  G A Blobel
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

3.  c-Myb acetylation at the carboxyl-terminal conserved domain by transcriptional co-activator p300.

Authors:  A Tomita; M Towatari; S Tsuzuki; F Hayakawa; H Kosugi; K Tamai; T Miyazaki; T Kinoshita; H Saito
Journal:  Oncogene       Date:  2000-01-20       Impact factor: 9.867

4.  CREB-Binding protein acetylates hematopoietic transcription factor GATA-1 at functionally important sites.

Authors:  H L Hung; J Lau; A Y Kim; M J Weiss; G A Blobel
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

5.  mSin3A regulates murine erythroleukemia cell differentiation through association with the TAL1 (or SCL) transcription factor.

Authors:  S Huang; S J Brandt
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

Review 6.  Erythroid Kruppel like factor: from fishing expedition to gourmet meal.

Authors:  A Perkins
Journal:  Int J Biochem Cell Biol       Date:  1999-10       Impact factor: 5.085

Review 7.  Basic Krüppel-like factor functions within a network of interacting haematopoietic transcription factors.

Authors:  J Turner; M Crossley
Journal:  Int J Biochem Cell Biol       Date:  1999-10       Impact factor: 5.085

8.  p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein.

Authors:  S Huang; Y Qiu; R W Stein; S J Brandt
Journal:  Oncogene       Date:  1999-09-02       Impact factor: 9.867

9.  P/CAF-mediated acetylation regulates the function of the basic helix-loop-helix transcription factor TAL1/SCL.

Authors:  S Huang; Y Qiu; Y Shi; Z Xu; S J Brandt
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

10.  Increased affinity of c-Myb for CREB-binding protein (CBP) after CBP-induced acetylation.

Authors:  Y Sano; S Ishii
Journal:  J Biol Chem       Date:  2000-11-09       Impact factor: 5.157

View more
  8 in total

1.  Mechanism for fetal hemoglobin induction by histone deacetylase inhibitors involves gamma-globin activation by CREB1 and ATF-2.

Authors:  Jose Sangerman; Moo Seung Lee; Xiao Yao; Eugene Oteng; Cheng-Hui Hsiao; Wei Li; Sima Zein; Solomon F Ofori-Acquah; Betty S Pace
Journal:  Blood       Date:  2006-08-08       Impact factor: 22.113

2.  Acetylation of lysine 564 adjacent to the C-terminal binding protein-binding motif in EVI1 is crucial for transcriptional activation of GATA2.

Authors:  Akiko Shimahara; Norio Yamakawa; Ichiro Nishikata; Kazuhiro Morishita
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

3.  MTA1, a transcriptional activator of breast cancer amplified sequence 3.

Authors:  Anupama E Gururaj; Rajesh R Singh; Suresh K Rayala; Caroline Holm; Petra den Hollander; Hao Zhang; Seetharaman Balasenthil; Amjad H Talukder; Goran Landberg; Rakesh Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-14       Impact factor: 11.205

Review 4.  Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents.

Authors:  Jiahuai Tan; Shundong Cang; Yuehua Ma; Richard L Petrillo; Delong Liu
Journal:  J Hematol Oncol       Date:  2010-02-04       Impact factor: 17.388

5.  GATA-2 functions downstream of BMPs and CaM KIV in ectodermal cells during primitive hematopoiesis.

Authors:  Gokhan Dalgin; Devorah C Goldman; Nathan Donley; Riffat Ahmed; Christopher A Eide; Jan L Christian
Journal:  Dev Biol       Date:  2007-08-16       Impact factor: 3.582

6.  Sirtuin 6 promotes eosinophil differentiation by activating GATA-1 transcription factor.

Authors:  In Hyuk Bang; Dami Park; Youngyi Lee; Hwangeui Cho; Byung-Hyun Park; Eun Ju Bae
Journal:  Aging Cell       Date:  2021-06-14       Impact factor: 9.304

7.  Drosophila histone deacetylase-3 controls imaginal disc size through suppression of apoptosis.

Authors:  Changqi C Zhu; Douglas J Bornemann; David Zhitomirsky; Ellen L Miller; Michael B O'Connor; Jeffrey A Simon
Journal:  PLoS Genet       Date:  2008-02-29       Impact factor: 5.917

Review 8.  Hematopoietic Stem Cell Transcription Factors in Cardiovascular Pathology.

Authors:  Sushmitha Duddu; Rituparna Chakrabarti; Anuran Ghosh; Praphulla Chandra Shukla
Journal:  Front Genet       Date:  2020-10-16       Impact factor: 4.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.